264 related articles for article (PubMed ID: 35023349)
1. Neuromodulation of Inflammation to Treat Heart Failure With Preserved Ejection Fraction: A Pilot Randomized Clinical Trial.
Stavrakis S; Elkholey K; Morris L; Niewiadomska M; Asad ZUA; Humphrey MB
J Am Heart Assoc; 2022 Feb; 11(3):e023582. PubMed ID: 35023349
[TBL] [Abstract][Full Text] [Related]
2. Low-level transcutaneous vagus nerve stimulation attenuates cardiac remodelling in a rat model of heart failure with preserved ejection fraction.
Zhou L; Filiberti A; Humphrey MB; Fleming CD; Scherlag BJ; Po SS; Stavrakis S
Exp Physiol; 2019 Jan; 104(1):28-38. PubMed ID: 30398289
[TBL] [Abstract][Full Text] [Related]
3. Autonomic Neuromodulation Acutely Ameliorates Left Ventricular Strain in Humans.
Tran N; Asad Z; Elkholey K; Scherlag BJ; Po SS; Stavrakis S
J Cardiovasc Transl Res; 2019 Jun; 12(3):221-230. PubMed ID: 30560316
[TBL] [Abstract][Full Text] [Related]
4. Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trial.
Edelmann F; Wachter R; Schmidt AG; Kraigher-Krainer E; Colantonio C; Kamke W; Duvinage A; Stahrenberg R; Durstewitz K; Löffler M; Düngen HD; Tschöpe C; Herrmann-Lingen C; Halle M; Hasenfuss G; Gelbrich G; Pieske B;
JAMA; 2013 Feb; 309(8):781-91. PubMed ID: 23443441
[TBL] [Abstract][Full Text] [Related]
5. Isosorbide Dinitrate, With or Without Hydralazine, Does Not Reduce Wave Reflections, Left Ventricular Hypertrophy, or Myocardial Fibrosis in Patients With Heart Failure With Preserved Ejection Fraction.
Zamani P; Akers S; Soto-Calderon H; Beraun M; Koppula MR; Varakantam S; Rawat D; Shiva-Kumar P; Haines PG; Chittams J; Townsend RR; Witschey WR; Segers P; Chirinos JA
J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28219917
[TBL] [Abstract][Full Text] [Related]
6. TREAT AF (Transcutaneous Electrical Vagus Nerve Stimulation to Suppress Atrial Fibrillation): A Randomized Clinical Trial.
Stavrakis S; Stoner JA; Humphrey MB; Morris L; Filiberti A; Reynolds JC; Elkholey K; Javed I; Twidale N; Riha P; Varahan S; Scherlag BJ; Jackman WM; Dasari TW; Po SS
JACC Clin Electrophysiol; 2020 Mar; 6(3):282-291. PubMed ID: 32192678
[TBL] [Abstract][Full Text] [Related]
7. Resting ventricular-vascular function and exercise capacity in heart failure with preserved ejection fraction: a RELAX trial ancillary study.
Mohammed SF; Borlaug BA; McNulty S; Lewis GD; Lin G; Zakeri R; Semigran MJ; LeWinter M; Hernandez AF; Braunwald E; Redfield MM
Circ Heart Fail; 2014 Jul; 7(4):580-9. PubMed ID: 24833648
[TBL] [Abstract][Full Text] [Related]
8. Autonomic regulation therapy in chronic heart failure with preserved/mildly reduced ejection fraction: ANTHEM-HFpEF study results.
Kumar HU; Nearing BD; Mittal S; Premchand RK; Libbus I; DiCarlo LA; Amurthur B; KenKnight BH; Anand IS; Verrier RL
Int J Cardiol; 2023 Jun; 381():37-44. PubMed ID: 36934987
[TBL] [Abstract][Full Text] [Related]
9. Extended-Release Oral Milrinone for the Treatment of Heart Failure With Preserved Ejection Fraction.
Nanayakkara S; Byrne M; Mak V; Carter K; Dean E; Kaye DM
J Am Heart Assoc; 2020 Jul; 9(13):e015026. PubMed ID: 32552264
[TBL] [Abstract][Full Text] [Related]
10. Noninvasive Vagus Nerve Stimulation in Postural Tachycardia Syndrome: A Randomized Clinical Trial.
Stavrakis S; Chakraborty P; Farhat K; Whyte S; Morris L; Abideen Asad ZU; Karfonta B; Anjum J; Matlock HG; Cai X; Yu X
JACC Clin Electrophysiol; 2024 Feb; 10(2):346-355. PubMed ID: 37999672
[TBL] [Abstract][Full Text] [Related]
11. Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients With Heart Failure]): A Phase 2, Randomized, Sham-Controlled Trial.
Feldman T; Mauri L; Kahwash R; Litwin S; Ricciardi MJ; van der Harst P; Penicka M; Fail PS; Kaye DM; Petrie MC; Basuray A; Hummel SL; Forde-McLean R; Nielsen CD; Lilly S; Massaro JM; Burkhoff D; Shah SJ;
Circulation; 2018 Jan; 137(4):364-375. PubMed ID: 29142012
[TBL] [Abstract][Full Text] [Related]
12. Accelerometer-Measured Daily Activity in Heart Failure With Preserved Ejection Fraction: Clinical Correlates and Association With Standard Heart Failure Severity Indices.
Snipelisky D; Kelly J; Levine JA; Koepp GA; Anstrom KJ; McNulty SE; Zakeri R; Felker GM; Hernandez AF; Braunwald E; Redfield MM
Circ Heart Fail; 2017 Jun; 10(6):e003878. PubMed ID: 28588021
[TBL] [Abstract][Full Text] [Related]
13. Treating anemia in older adults with heart failure with a preserved ejection fraction with epoetin alfa: single-blind randomized clinical trial of safety and efficacy.
Maurer MS; Teruya S; Chakraborty B; Helmke S; Mancini D
Circ Heart Fail; 2013 Mar; 6(2):254-63. PubMed ID: 23258574
[TBL] [Abstract][Full Text] [Related]
14. Clinical and Echocardiographic Characteristics and Cardiovascular Outcomes According to Diabetes Status in Patients With Heart Failure and Preserved Ejection Fraction: A Report From the I-Preserve Trial (Irbesartan in Heart Failure With Preserved Ejection Fraction).
Kristensen SL; Mogensen UM; Jhund PS; Petrie MC; Preiss D; Win S; Køber L; McKelvie RS; Zile MR; Anand IS; Komajda M; Gottdiener JS; Carson PE; McMurray JJ
Circulation; 2017 Feb; 135(8):724-735. PubMed ID: 28052977
[TBL] [Abstract][Full Text] [Related]
15. Echocardiographic Features of Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction.
Shah AM; Cikes M; Prasad N; Li G; Getchevski S; Claggett B; Rizkala A; Lukashevich I; O'Meara E; Ryan JJ; Shah SJ; Mullens W; Zile MR; Lam CSP; McMurray JJV; Solomon SD;
J Am Coll Cardiol; 2019 Dec; 74(23):2858-2873. PubMed ID: 31806129
[TBL] [Abstract][Full Text] [Related]
16. IL-1 Blockade in Patients With Heart Failure With Preserved Ejection Fraction.
Van Tassell BW; Trankle CR; Canada JM; Carbone S; Buckley L; Kadariya D; Del Buono MG; Billingsley H; Wohlford G; Viscusi M; Oddi-Erdle C; Abouzaki NA; Dixon D; Biondi-Zoccai G; Arena R; Abbate A
Circ Heart Fail; 2018 Aug; 11(8):e005036. PubMed ID: 30354558
[TBL] [Abstract][Full Text] [Related]
17. Lifestyle Walking Intervention for Patients With Heart Failure With Reduced Ejection Fraction: The WATCHFUL Trial.
Vetrovsky T; Siranec M; Frybova T; Gant I; Svobodova I; Linhart A; Parenica J; Miklikova M; Sujakova L; Pospisil D; Pelouch R; Odrazkova D; Parizek P; Precek J; Hutyra M; Taborsky M; Vesely J; Griva M; Semerad M; Bunc V; Hrabcova K; Vojkuvkova A; Svoboda M; Belohlavek J;
Circulation; 2024 Jan; 149(3):177-188. PubMed ID: 37955615
[TBL] [Abstract][Full Text] [Related]
18. Non-pharmacologic autonomic neuromodulation for treatment of heart failure: A systematic review and meta-analysis of randomized controlled trials.
Ahmed M; Nudy M; Bussa R; Weigel F; Naccarelli G; Maheshwari A
Trends Cardiovasc Med; 2024 Feb; 34(2):101-107. PubMed ID: 36202286
[TBL] [Abstract][Full Text] [Related]
19. Effect of Dapagliflozin on 6-Minute Walk Distance in Heart Failure With Preserved Ejection Fraction: PRESERVED-HF.
Lewis GD; Gosch K; Cohen LP; Nassif ME; Windsor SL; Borlaug BA; Kitzman DW; Shah SJ; Khumri T; Umpierrez G; Lamba S; Sharma K; Khan SS; Kosiborod MN; Sauer AJ
Circ Heart Fail; 2023 Nov; 16(11):e010633. PubMed ID: 37869881
[TBL] [Abstract][Full Text] [Related]
20. Autonomic regulation therapy to enhance myocardial function in heart failure patients: the ANTHEM-HFpEF study.
DiCarlo LA; Libbus I; Kumar HU; Mittal S; Premchand RK; Amurthur B; KenKnight BH; Ardell JL; Anand IS
ESC Heart Fail; 2018 Feb; 5(1):95-100. PubMed ID: 29283224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
